A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer’s Disease ; day:2 ; month:7 ; year:2024 ; pages:1-13
The journal of prevention of Alzheimer's disease ; (2.7.2024), 1-13
- Urheber
-
Chen, Tianle
Hutchison, R. M.
Rubel, C.
Murphy, J.
Xie, J.
Montenigro, P.
Cheng, W.
Fraser, K.
Dent, G.
Hendrix, S.
Hansson, O.
Aisen, P.
Tian, Y.
O’Gorman, J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2024.126
- URN
-
urn:nbn:de:101:1-2409202135397.794618121022
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Tianle
- Hutchison, R. M.
- Rubel, C.
- Murphy, J.
- Xie, J.
- Montenigro, P.
- Cheng, W.
- Fraser, K.
- Dent, G.
- Hendrix, S.
- Hansson, O.
- Aisen, P.
- Tian, Y.
- O’Gorman, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Imaging endpoints for clinical trials in Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Current state of Alzheimer’s fluid biomarkers
Fluid biomarkers in Alzheimer’s disease – current concepts
Blood-based molecular biomarkers for Alzheimer’s disease
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Imaging endpoints for clinical trials in Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Current state of Alzheimer’s fluid biomarkers
Fluid biomarkers in Alzheimer’s disease – current concepts
Blood-based molecular biomarkers for Alzheimer’s disease
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Imaging endpoints for clinical trials in Alzheimer’s disease
Biomarkers in Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Current state of Alzheimer’s fluid biomarkers
Fluid biomarkers in Alzheimer’s disease – current concepts
Blood-based molecular biomarkers for Alzheimer’s disease
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer’s Disease
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative